Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5382600 (Pediatric) | UPJOHN | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
Sep, 2012
(11 years ago) |
Market Authorisation Date: 25 March, 1998
Treatment: NA
Dosage: TABLET;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5382600 (Pediatric) | UPJOHN | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
Sep, 2012
(11 years ago) | |
US6770295 | UPJOHN | Therapeutic formulation for administering tolterodine with controlled release |
Aug, 2019
(4 years ago) | |
US6630162 | UPJOHN | Pharmaceutical formulation and its use |
Nov, 2019
(4 years ago) | |
US6911217 | UPJOHN | Controlled release bead, a method of producing the same and multiple unit formulation comprising it |
Nov, 2019
(4 years ago) | |
US6770295 (Pediatric) | UPJOHN | Therapeutic formulation for administering tolterodine with controlled release |
Feb, 2020
(4 years ago) | |
US6911217 (Pediatric) | UPJOHN | Controlled release bead, a method of producing the same and multiple unit formulation comprising it |
May, 2020
(3 years ago) | |
US6630162 (Pediatric) | UPJOHN | Pharmaceutical formulation and its use |
May, 2020
(3 years ago) |
Market Authorisation Date: 22 December, 2000
Treatment: Treatment of overactive bladder. treatment of urinary incontinence.
Dosage: CAPSULE, EXTENDED RELEASE;ORAL